Seccoside announced that the company's board of directors reviewed and passed the bill, agreed to cancel the holding subsidiary Secauceed Medical Devices Co., Ltd., and authorized management to handle liquidation, cancellation and other related matters. The subsidiary has a registered capital of 10 million yuan, and the company holds 80% of the shares; as of June 30, 2026, its total assets were 1.1553 million yuan, net assets were 1,0553 million yuan, revenue for the first half of 2026 was 0.65 million yuan, and a net loss of 161,700 yuan. This cancellation does not constitute a related transaction or major asset restructuring, and will not have a substantial adverse impact on the company's production and operation after completion.

Seccoside announced that the company's board of directors reviewed and passed the bill, agreed to cancel the holding subsidiary Secauceed Medical Devices Co., Ltd., and authorized management to handle liquidation, cancellation and other related matters. The subsidiary has a registered capital of 10 million yuan, and the company holds 80% of the shares; as of June 30, 2026, its total assets were 1.1553 million yuan, net assets were 1,0553 million yuan, revenue for the first half of 2026 was 0.65 million yuan, and a net loss of 161,700 yuan. This cancellation does not constitute a related transaction or major asset restructuring, and will not have a substantial adverse impact on the company's production and operation after completion.